查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2030302

生物淨化市場－全球產業規模、佔有率、趨勢、機會和預測：按產品、試劑類型、地區和競爭格局分類，2021-2031年

Bio Decontamination Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Agent Type, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球生物淨化市場預計將從 2025 年的 2.3101 億美元成長到 2031 年的 3.0291 億美元，複合年成長率為 4.62%。

該市場涵蓋旨在減少或去除設備、表面和受控區域內生物污染物（例如孢子、病毒和細菌）的服務和產品，以達到所需的無菌水平。推動這一成長的關鍵因素包括：醫藥和醫療領域國際法規的日益完善、對預防醫療相關感染的日益重視，以及生物製藥行業的持續擴張（該行業需要完善的生產環境）。阻礙市場發展的主要障礙是購買先進的生物淨化設備和實施全面的驗證程序所需的大量資金投入。儘管過去一年行業協會提供的市場規模統計數據有時不夠準確，但該領域的活躍狀況顯而易見。正如醫療設備促進協會 (AAMI) 在 2026 年 1 月指出的那樣，該組織擁有約 15,000 名企業和個人會員，致力於推進醫療技術的發展，這凸顯了廣泛的專業人士網路的存在，他們致力於安全的醫療實踐，而生物淨化在其中發揮著至關重要的作用。

市場概覽
預測期 2027-2031
市場規模：2025年 231,010,000 美元
市場規模：2031年 3.0291億美元
複合年成長率：2026-2031年 4.62%
成長最快的細分市場 裝置
最大的市場 北美洲

市場促進因素

生物技術和製藥產業的快速發展是全球生物淨化市場的主要驅動力，因為其生產和研發環節都需要嚴格的無菌環境。隨著先進治療方法和生物製藥的日益複雜，必須採取嚴格的污染控制措施來確保病患安全和產品品質。美國食品藥物管理局（FDA）藥物評估與研究中心在2025年核准了46種新藥，這印證了這個趨勢，顯示大量藥物研發管線需要符合標準的生產環境。製造業的穩定發展和擴張直接推動了對先進生物淨化服務和工具的需求，以維持必要的衛生標準。同時，醫療相關感染（HAI）發生率的不斷上升是另一個重要的成長要素，凸顯了持續實施嚴格感染控制措施的必要性。根據美國疾病管制與預防中心（CDC）於2026年1月發布的2024財政年度年度進展報告，每天住院病患中約有1/31會發生醫院感染（HAI）。為了應對這一持續存在的問題，廣泛採用可靠的空氣、表面和醫療設備生物消毒方法至關重要。此外，該產業正獲得巨額投資，製藥公司表示計劃在未來五年內向美國製造地投資超過3,700億美元。根據PharmaVoice於2026年1月發布的報告，其中包括許多計劃於2026年投產的設施。如此大規模的生物製造設施投資凸顯了生物消毒的關鍵重要性。

市場挑戰

全球生物淨化市場成長面臨的主要障礙之一是先進設備和嚴格驗證程序所需的大量資本投入。對於預算有限的中小型企業 (SME) 和組織而言，這項財務門檻尤為突出，導致其無法及時採用現代化、高效的淨化系統。購買用於氣態甲醛和氣態過氧化氫等方法的專用設備的初始成本，以及聘請培訓人員和完成全面的合規性驗證所需的費用，都構成了沉重的財務負擔。這常常影響採購決策，導致交貨週期延長和關鍵設施升級延誤，限制了市場擴張和普及。這些高昂的初始成本也會顯著影響企業對投資報酬率 (ROI) 的評估，使得價格較低的方案更具吸引力，即使這些方案會犧牲一定的可靠性或有效性。儘管整個產業已投入巨資，但這項挑戰依然存在。例如，2025 年 10 月，美國製藥製造商協會 (PhRMA) 宣布，其成員公司已承諾投入 5,000 億美元，用於建造美國境內的新型生產基礎設施。雖然大部分資金都用於建造和維護無菌工作空間，但生物消毒工具的高昂成本以及相關的檢驗要求仍然是一個財務瓶頸，阻礙了整個行業的更廣泛採用。

市場趨勢

物聯網技術在即時追蹤方面的應用對生物消毒流程產生了重大影響，因為它能夠對設備性能和環境因素進行不間斷的監測。這項進步使企業能夠利用壓力差和空氣品質等關鍵因素的即時指標，從而將污染控制從被動反應轉變為主動預防。這些功能對於及早發現異常至關重要，並能實現快速糾正措施，從而降低敏感環境中的污染風險。例如，HVACTechnocrat.com 在 2025 年 4 月報道稱，孟買一家製藥公司在部署物聯網連接的感測器進行即時追蹤後，污染事件減少了 35%。同時，自動化消毒設備的日益普及正在改變產業的運作方式。這些系統顯著減少了對人工的依賴，確保消毒劑的均勻分佈，並減少人為錯誤，這對於實現一致且可驗證的無菌狀態至關重要。自動化使企業能夠在遵守嚴格監管規定的同時，透過標準化的清潔流程來提高整個工作流程的效率。為了支持這一趨勢，《製藥雜誌》在 2026 年 4 月報道稱，貝齊·卡德瓦拉多爾大學健康委員會已於 2025 年為其官方製造中心購買了可攜式過氧化氫蒸氣發生器，這表明已明顯轉向經過檢驗的自動化技術。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球生物淨化市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依產品（設備、服務、耗材）分類
    • 依化學物質類型（過氧化氫、二氧化氯、過氧乙酸、二氧化氮等）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美生物淨化市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲生物淨化市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區生物淨化市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲生物淨化市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲生物淨化市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球生物淨化市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Ecolab, Inc.
  • ClorDiSys Solutions, Inc.
  • JCE Biotechnology
  • Howorth Air Technology Limited
  • PMT（USA）LLC
  • Zhejiang Tailin Bioengineering Co., Ltd.
  • Fedegari Autoclavi SpA
  • TOMI Environmental Solutions Inc.
  • Amira Srl
  • STERIS Life Science PLC

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 5105

The Global Bio Decontamination Market is anticipated to expand from USD 231.01 million in 2025 to USD 302.91 million by 2031, experiencing a CAGR of 4.62%. This market includes services and products designed to decrease or eradicate biological pollutants like spores, viruses, and bacteria from equipment, surfaces, and controlled areas to reach necessary sterility levels. Growth is primarily fueled by stricter international regulations in the pharmaceutical and healthcare fields, a growing focus on stopping healthcare-associated infections, and the ongoing expansion of the biopharmaceutical sector, which demands flawless manufacturing environments.\nA major obstacle hindering market progress is the substantial financial investment needed to purchase sophisticated bio-decontamination machinery and execute thorough validation procedures. Although exact market sizing statistics from industry groups for the past year are occasionally lacking, high activity levels in the field remain clear. As noted by the Association for the Advancement of Medical Instrumentation in January 2026, the group had roughly 15,000 corporate and individual members focused on progressing medical technology, highlighting a large network of professionals committed to safe healthcare practices where bio-decontamination plays a vital role.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 231.01 Million
Market Size 2031USD 302.91 Million
CAGR 2026-20314.62%
Fastest Growing SegmentEquipment
Largest MarketNorth America

Market Driver

The rapid development of the biotechnology and pharmaceutical sectors serves as a major catalyst for the Global Bio Decontamination Market, given their need for strictly sterile conditions during manufacturing, research, and development. As advanced therapies and biologics become more complex, rigorous contamination management is required to guarantee patient safety and product quality. Highlighting this trend, the FDA's Center for Drug Evaluation and Research approved 46 new drugs in 2025, reflecting a strong pipeline of pharmaceuticals that require compliant production environments. Such steady progress and expansion in manufacturing directly boost the need for sophisticated bio-decontamination services and tools to uphold essential hygiene standards.\nAt the same time, the growing frequency of healthcare-associated infections (HAIs) acts as a vital growth driver, emphasizing the ongoing necessity for strict infection control measures. As detailed in the Centers for Disease Control and Prevention's 2024 annual progress report published in January 2026, roughly one out of every 31 hospital patients suffers from an HAI on any specific day. This ongoing issue requires the broad implementation of reliable bio-decontamination methods for air, surfaces, and medical equipment. Furthermore, the industry is seeing massive capital injections, with pharmaceutical firms revealing intentions to invest more than $370 billion in United States manufacturing over the next half-decade, including numerous facilities planned for 2026 as per a January 2026 PharmaVoice report. This level of funding in biomanufacturing facilities highlights the critical importance of bio-decontamination.

Market Challenge

A major obstacle hindering the growth of the Global Bio Decontamination Market is the hefty financial investment needed for sophisticated machinery and strict validation procedures. This monetary hurdle is especially difficult for smaller businesses and organizations with restricted budgets, delaying the integration of modern, highly efficient decontamination systems. The initial expenses associated with purchasing specialized equipment for methods such as gaseous formaldehyde or vaporized hydrogen peroxide, alongside the costs of hiring trained staff and completing thorough validations for regulatory compliance, result in a heavy financial strain. Consequently, this influences buying choices, frequently causing longer purchasing timelines or the postponement of crucial facility upgrades, which limits market expansion and adoption.\nThese steep upfront costs also heavily affect the return on investment assessments of prospective purchasers, causing cheaper options to appear more attractive even if they sacrifice some decontamination reliability or effectiveness. This challenge persists despite massive financial commitments across the sector; for instance, the Pharmaceutical Research and Manufacturers of America (PhRMA) noted in October 2025 that its members pledged $500 billion toward new manufacturing infrastructure in the United States. While a large segment of these funds is dedicated to creating and sustaining sterile workspaces, the steep price of bio-decontamination tools and their necessary validation continues to act as a financial bottleneck, restricting more extensive adoption throughout the industry.

Market Trends

Incorporating IoT technology for live tracking has a massive effect on bio-decontamination procedures by providing uninterrupted observation of machinery performance and environmental factors. This advancement empowers organizations to move from reactive to preventative contamination management by leveraging instant metrics on essential factors such as pressure differences and air quality. These features are crucial for spotting irregularities early, allowing for quick corrections that reduce the threat of contamination in delicate settings. For example, HVACTechnocrat.com reported in April 2025 that a pharmaceutical firm in Mumbai integrated IoT-connected sensors for live tracking, leading to a 35% decrease in contamination events.\nAt the same time, the growing use of automated decontamination equipment is transforming operational practices within the industry. By drastically lowering the need for manual involvement, these systems guarantee a uniform distribution of sterilizing agents and cut down on human mistakes, a vital factor for reaching consistent and provable sterility. Automation helps organizations adhere to strict regulatory rules while boosting overall workflow efficiency through standardized cleaning procedures. Highlighting this trend, The Pharmaceutical Journal reported in April 2026 that the Betsi Cadwaladr University Health Board purchased a mobile vaporized hydrogen peroxide generator in 2025 for its official manufacturing center, demonstrating a clear shift toward validated, automated technologies.

Key Market Players

  • Ecolab, Inc.
  • ClorDiSys Solutions, Inc.
  • JCE Biotechnology
  • Howorth Air Technology Limited
  • PMT (USA) LLC
  • Zhejiang Tailin Bioengineering Co., Ltd.
  • Fedegari Autoclavi SpA
  • TOMI Environmental Solutions Inc.
  • Amira Srl
  • STERIS Life Science PLC

Report Scope

In this report, the Global Bio Decontamination Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Bio Decontamination Market, By Product

  • Equipment
  • Services
  • Consumables

Bio Decontamination Market, By Agent Type

  • Hydrogen Peroxide
  • Chlorine Dioxide
  • Peracetic Acid
  • Nitrogen Dioxide
  • Others

Bio Decontamination Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Bio Decontamination Market.

Available Customizations:

Global Bio Decontamination Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Bio Decontamination Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Equipment, Services, Consumables)
    • 5.2.2. By Agent Type (Hydrogen Peroxide, Chlorine Dioxide, Peracetic Acid, Nitrogen Dioxide, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Bio Decontamination Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Agent Type
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Bio Decontamination Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Agent Type
    • 6.3.2. Canada Bio Decontamination Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Agent Type
    • 6.3.3. Mexico Bio Decontamination Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Agent Type

7. Europe Bio Decontamination Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Agent Type
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Bio Decontamination Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Agent Type
    • 7.3.2. France Bio Decontamination Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Agent Type
    • 7.3.3. United Kingdom Bio Decontamination Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Agent Type
    • 7.3.4. Italy Bio Decontamination Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Agent Type
    • 7.3.5. Spain Bio Decontamination Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Agent Type

8. Asia Pacific Bio Decontamination Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Agent Type
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Bio Decontamination Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Agent Type
    • 8.3.2. India Bio Decontamination Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Agent Type
    • 8.3.3. Japan Bio Decontamination Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Agent Type
    • 8.3.4. South Korea Bio Decontamination Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Agent Type
    • 8.3.5. Australia Bio Decontamination Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Agent Type

9. Middle East & Africa Bio Decontamination Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Agent Type
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Bio Decontamination Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Agent Type
    • 9.3.2. UAE Bio Decontamination Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Agent Type
    • 9.3.3. South Africa Bio Decontamination Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Agent Type

10. South America Bio Decontamination Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Agent Type
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Bio Decontamination Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Agent Type
    • 10.3.2. Colombia Bio Decontamination Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Agent Type
    • 10.3.3. Argentina Bio Decontamination Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Agent Type

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Bio Decontamination Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Ecolab, Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. ClorDiSys Solutions, Inc.
  • 15.3. JCE Biotechnology
  • 15.4. Howorth Air Technology Limited
  • 15.5. PMT (USA) LLC
  • 15.6. Zhejiang Tailin Bioengineering Co., Ltd.
  • 15.7. Fedegari Autoclavi SpA
  • 15.8. TOMI Environmental Solutions Inc.
  • 15.9. Amira Srl
  • 15.10. STERIS Life Science PLC

16. Strategic Recommendations

17. About Us & Disclaimer